Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report
Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report
Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.
Monitoring and management of AE's during antineoplastic treatment. Comparison of AE's reported by patient with the ones recognised by the oncologist, and vice versa, during antineoplastic treatment.
Inclusion Criteria:
all cancer patients receiving systemic antineoplastic treatment, ECOG 0-2
Exclusion Criteria:
age <18, >75; other active and severe comorbidities; no solid cancer; IUC patients